{
    "nctId": "NCT03629717",
    "briefTitle": "RANKL Inhibition and Breast Tissue Biomarkers",
    "officialTitle": "RANKL Inhibition and Breast Tissue Biomarkers in Premenopausal Women With Dense Breasts",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Prevention, Mammographic Density",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Effect of denosumab on breast tissue gene pathway gene expression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female.\n* Premenopausal.\n* At least 35 years of age.\n* Dense breasts on routine mammogram.\n* Willing to take calcium (1,200mg) and vitamin D (800 IU) daily.\n* At increased risk for breast cancer using any of the following:\n\n  * Positive family history of breast cancer\n  * Breast cancer risk prediction models\n* Able and willing to return for repeat biopsy.\n* Able to understand and willing to sign an IRB-approved written informed consent document.\n\nExclusion Criteria:\n\n* Current use of tamoxifen, aromatase inhibitors, or bisphosphonates.\n* Concurrently participating in another cancer chemoprevention trial (unless no longer receiving the intervention).\n* Pregnant or lactating.\n* Recent tooth extraction or dental procedure.\n* Unhealed and/or planned dental/oral surgery.\n* History of osteonecrosis/osteomyelitis of the jaw.\n* History of osteoporosis or severe osteopenia.\n* Unable/unwilling to return for repeat biopsy.",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}